{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T21:33:34Z","timestamp":1767648814753,"version":"build-2065373602"},"reference-count":30,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2024,10,20]],"date-time":"2024-10-20T00:00:00Z","timestamp":1729382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["2P30CA016058"],"award-info":[{"award-number":["2P30CA016058"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Introduction: Congruent with most guideline publishers, the Canadian Urological Association (CUA) recommends shared decision-making (SDM) on PSA screening (PSAS) for prostate cancer (PCa) following a discussion of its benefits and harms. However, there are limited data on how the general male population feels about these topics. Methods: A survey was completed by 906 male-identifying participants (age &gt; 18) recruited via Amazon Mechanical Turk (MTurk), which is a crowdsourcing platform providing minimal compensation. Participants answered questions regarding demographics (15), personal\/family history (9), PCa\/PSA knowledge (41), and opinions regarding PSAS (45). Results: The median age was 38.2 (SD = 12.0), with 22% reporting a family history of PCa and 20% reporting personally undergoing PSAS. Although most participants had heard of PCa (85%) and that they could be screened for it (81%), they generally did not feel knowledgeable about PCa or PSAS guidelines. Most want to talk to their clinician about PCa and PSAS (74%) and are supportive of SDM (48%) or patient-centered decision-making (25%). In general, participants thought PSAS was still worthwhile, even if it led to additional testing or side effects. Similarly, participants thought higher-risk patients should be screened earlier (p &lt; 0.001). A number of misconceptions were evident in the responses. Conclusions: Men approaching the age of PSAS do not feel knowledgeable about PCa or PSAS and want their clinician to discuss these topics with them. The majority believe in PSAS and would like to undergo this screening following SDM. Clinicians also have a role in correcting common misconceptions about PCa.<\/jats:p>","DOI":"10.3390\/curroncol31100475","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T07:53:43Z","timestamp":1729583623000},"page":"6395-6405","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Perspectives and Misconceptions of an Online Adult Male Cohort Regarding Prostate Cancer Screening"],"prefix":"10.3390","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4440-1477","authenticated-orcid":false,"given":"Tyler","family":"Sheetz","sequence":"first","affiliation":[{"name":"Division of Urologic Oncology, Department of Urology, The Ohio State University Comprehensive Cancer Center, 2121 Kenny Road, Columbus, OH 43210, USA"},{"name":"Department of Urology, University of California San Diego, 200 West Arbor Drive, San Diego, CA 92103, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tasha","family":"Posid","sequence":"additional","affiliation":[{"name":"Division of Urologic Oncology, Department of Urology, The Ohio State University Comprehensive Cancer Center, 2121 Kenny Road, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliza","family":"Khuhro","sequence":"additional","affiliation":[{"name":"Division of Urologic Oncology, Department of Urology, The Ohio State University Comprehensive Cancer Center, 2121 Kenny Road, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Scimeca","sequence":"additional","affiliation":[{"name":"Division of Urologic Oncology, Department of Urology, The Ohio State University Comprehensive Cancer Center, 2121 Kenny Road, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Beebe","sequence":"additional","affiliation":[{"name":"Division of Urologic Oncology, Department of Urology, The Ohio State University Comprehensive Cancer Center, 2121 Kenny Road, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Essa","family":"Gul","sequence":"additional","affiliation":[{"name":"Division of Urologic Oncology, Department of Urology, The Ohio State University Comprehensive Cancer Center, 2121 Kenny Road, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn","family":"Dason","sequence":"additional","affiliation":[{"name":"Division of Urologic Oncology, Department of Urology, The Ohio State University Comprehensive Cancer Center, 2121 Kenny Road, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa0810696","article-title":"Mortality results from a randomized prostate-cancer screening trial","volume":"360","author":"Andriole","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1056\/NEJMp1109283","article-title":"Shared decision making\u2014The pinnacle of patient-centered care","volume":"366","author":"Barry","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/UPJ.0000000000000267","article-title":"Testicular Cancer Knowledge and Viewpoints of American Men","volume":"9","author":"Beebe","year":"2022","journal-title":"Urol. Pract."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3912\/OJIN.Vol21No01Man01","article-title":"The Patient Experience and Patient Satisfaction: Measurement of a Complex Dynamic","volume":"21","author":"Berkowitz","year":"2016","journal-title":"Online J. Issues Nurs."},{"key":"ref_5","unstructured":"Bureau, U.S.C. (2024, June 01). Unites States Census Quick Facts, Available online: https:\/\/www.census.gov\/quickfacts\/fact\/table\/US\/PST045221."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ssmph.2015.11.003","article-title":"Adherence to clinical preventive services guidelines: Population-based online randomized trial","volume":"1","author":"Evans","year":"2015","journal-title":"SSM Popul. Health"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s10900-011-9383-5","article-title":"Factors influencing men\u2019s decisions regarding prostate cancer screening: A qualitative study","volume":"36","author":"Ferrante","year":"2011","journal-title":"J. Community Health"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4111\/icu.2017.58.6.423","article-title":"US Preventive Services Task Force prostate-specific antigen screening guidelines result in higher Gleason score diagnoses","volume":"58","author":"Gejerman","year":"2017","journal-title":"Investig. Clin. Urol."},{"key":"ref_9","first-page":"5875","article-title":"Screening for Prostate Cancer: The Current Evidence and Guidelines Controversy","volume":"18","author":"Gomella","year":"2011","journal-title":"Can. J. Urol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2018.3710","article-title":"Screening for Prostate Cancer","volume":"319","author":"Force","year":"2018","journal-title":"JAMA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1370\/afm.1539","article-title":"National evidence on the use of shared decision making in prostate-specific antigen screening","volume":"11","author":"Han","year":"2013","journal-title":"Ann. Fam. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pec.2008.08.013","article-title":"The relationship between prostate cancer knowledge and beliefs and intentions to attend PSA screening among at-risk men","volume":"74","author":"Hevey","year":"2009","journal-title":"Patient Educ. Couns."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41391-020-0227-1","article-title":"Shared decision making and prostate-specific antigen based prostate cancer screening following the 2018 update of USPSTF screening guideline","volume":"24","author":"Jiang","year":"2021","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/jamaoncol.2021.5143","article-title":"Changes in Prostate-Specific Antigen Testing Relative to the Revised US Preventive Services Task Force Recommendation on Prostate Cancer Screening","volume":"8","author":"Leapman","year":"2021","journal-title":"JAMA Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s13187-021-02075-2","article-title":"Quality Assessment of Online Resources for the Most Common Cancers","volume":"38","author":"Li","year":"2021","journal-title":"J. Cancer Educ."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"E184","DOI":"10.5489\/cuaj.7851","article-title":"UPDATE\u20142022 Canadian Urological Association recommendations on prostate cancer screening and early diagnosis: Endorsement of the 2021 Cancer Care Ontario guidelines on prostate multiparametric magnetic resonance imaging","volume":"16","author":"Mason","year":"2022","journal-title":"Can. Urol. Assoc. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s12160-013-9508-4","article-title":"Classifying the reasons men consider to be important in prostate-specific antigen (psa) testing decisions: Evaluating risks, lay beliefs, and informed decisions","volume":"46","author":"McDowell","year":"2013","journal-title":"Ann. Behav. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/medethics-2019-105979","article-title":"A discussion on controversies and ethical dilemmas in prostate cancer screening","volume":"47","author":"Mishra","year":"2020","journal-title":"J. Med. Ethic"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/cncr.33239","article-title":"Impact of health literacy on shared decision making for prostate-specific antigen screening in the United States","volume":"127","author":"Nguyen","year":"2021","journal-title":"Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/pon.3721","article-title":"Prostate cancer survivors\u2019 beliefs about screening and treatment decision-making experiences in an era of controversy","volume":"24","author":"Orom","year":"2015","journal-title":"Psycho-Oncology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/1740774510374091","article-title":"Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial","volume":"7","author":"Pinsky","year":"2010","journal-title":"Clin. Trials"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1007\/s13187-020-01904-0","article-title":"Current Knowledge and Opinions of Medical Trainees Regarding PSA Screening","volume":"37","author":"Sheetz","year":"2022","journal-title":"J. Cancer Educ."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3122\/jabfm.2021.04.200632","article-title":"Quality of YouTube Videos on Prostate Cancer Screening for Black Men","volume":"34","author":"Shungu","year":"2021","journal-title":"J. Am. Board Fam. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.amepre.2013.04.005","article-title":"Prostate-specific antigen testing: Men\u2019s responses to 2012 recommendation against screening","volume":"45","author":"Squiers","year":"2013","journal-title":"Am. J. Prev. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1056\/NEJM198710083171501","article-title":"Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate","volume":"317","author":"Stamey","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e005691","DOI":"10.1136\/bmjopen-2014-005691","article-title":"Deliberative democracy and cancer screening consent: A randomised control trial of the effect of a community jury on men\u2019s knowledge about and intentions to participate in PSA screening","volume":"4","author":"Thomas","year":"2014","journal-title":"BMJ Open"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/1557988316644979","article-title":"rostate Cancer Ambassadors: Process and Outcomes of a Prostate Cancer Informed Decision-Making Training Program","volume":"11","author":"Vines","year":"2017","journal-title":"Am. J. Men\u2019s Health"},{"key":"ref_28","unstructured":"Wei, J., Barocas, D., and Carlsson, S. (2024, June 01). Early Detection of Prostate Cancer: AUA\/SUO Guideline (2023)\u2014American Urological Association. 2023, 1\u201347. Available online: https:\/\/www.auanet.org\/guidelines-and-quality\/guidelines\/early-detection-of-prostate-cancer-guidelines."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/pcan.2016.30","article-title":"Increasing incidence of metastatic prostate cancer in the United States (2004\u20132013)","volume":"19","author":"Weiner","year":"2016","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41391-021-00473-7","article-title":"Instagram and prostate cancer: Using validated instruments to assess the quality of information on social media","volume":"25","author":"Xu","year":"2021","journal-title":"Prostate Cancer Prostatic Dis."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/31\/10\/475\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:16:57Z","timestamp":1760113017000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/31\/10\/475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,20]]},"references-count":30,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["curroncol31100475"],"URL":"https:\/\/doi.org\/10.3390\/curroncol31100475","relation":{},"ISSN":["1718-7729"],"issn-type":[{"type":"electronic","value":"1718-7729"}],"subject":[],"published":{"date-parts":[[2024,10,20]]}}}